1. The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer
   Kang Wu et al, 2024, Toxicology and Applied Pharmacology CrossRef
2. The tumorigenic effect of the high expression of ABRACL in glioma and its potential as a therapeutic target
   Chenhui Zhao et al, 2024, Heliyon CrossRef
3. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
   Lin Dong et al, 2024, Cancer Letters CrossRef
4. STAT3 Regulates the Redox Profile in MDA-MB-231 Breast Cancer Cells
   Juliana Alves Rodrigues et al, 2024, Cell Biochemistry and Biophysics CrossRef
5. Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation
   M. Kovář et al, 2024, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
6. Pharmacological inhibition reveals participation of the endocytic compartment in positive feedback IL-6 secretion in human skeletal myotubes
   Blanca Calle-Ciborro et al, 2024, European Journal of Pharmacology CrossRef
7. A novel STAT3/ NFκB p50 axis regulates stromal-KDM2A to promote M2 macrophage-mediated chemoresistance in breast cancer
   Jia-Shing Chen et al, 2023, Cancer Cell International CrossRef
8. Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
   Dandan Shi et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef